Healthcare provider profile · identity verified

Timothy A Tobin, MD

Internal Medicine · ESSEX, CT · NPI 1184669566

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	580	117
Lisinopril	Lisinopril	433	82
Pantoprazole Sodium	Pantoprazole Sodium	279	57
Amlodipine Besylate	Amlodipine Besylate	270	53
Levothyroxine Sodium	Levothyroxine Sodium	262	48
Eliquis	Apixaban	235	27
Alprazolam	Alprazolam	204	38
Tamsulosin Hcl	Tamsulosin Hcl	175	37
Metoprolol Succinate	Metoprolol Succinate	169	33
Omeprazole	Omeprazole	169	35
Meloxicam	Meloxicam	157	48
Metformin Hcl	Metformin Hcl	155	40
Escitalopram Oxalate	Escitalopram Oxalate	152	31
Trazodone Hcl	Trazodone Hcl	148	36
Oxycodone Hcl	Oxycodone Hcl	145	16
Hydrochlorothiazide	Hydrochlorothiazide	142	31
Rosuvastatin Calcium	Rosuvastatin Calcium	140	28
Simvastatin	Simvastatin	138	27
Losartan Potassium	Losartan Potassium	137	32
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	136	14
Furosemide	Furosemide	131	28
Gabapentin	Gabapentin	131	26
Lorazepam	Lorazepam	83	17
Metoprolol Tartrate	Metoprolol Tartrate	80	17
Citalopram Hbr	Citalopram Hydrobromide	79	12
Fluticasone Propionate	Fluticasone Propionate	78	38
Potassium Chloride	Potassium Chloride	77	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	76	26
Allopurinol	Allopurinol	72	15
Mirtazapine	Mirtazapine	71	13
Carvedilol	Carvedilol	68	14
Jardiance	Empagliflozin	62	18
Lovastatin	Lovastatin	62	13
Prednisone	Prednisone	62	30
Tramadol Hcl	Tramadol Hcl	62	24
Myrbetriq	Mirabegron	61	suppressed
Montelukast Sodium	Montelukast Sodium	57	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	54	suppressed
Pravastatin Sodium	Pravastatin Sodium	54	14
Jentadueto	Linagliptin/Metformin Hcl	53	suppressed
Pregabalin	Pregabalin	53	11
Sertraline Hcl	Sertraline Hcl	52	suppressed
Famotidine	Famotidine	48	suppressed
Breo Ellipta	Fluticasone/Vilanterol	45	suppressed
Diazepam	Diazepam	45	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	suppressed
Bupropion Xl	Bupropion Hcl	42	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	42	suppressed
Ibuprofen	Ibuprofen	41	suppressed
Finasteride	Finasteride	39	suppressed
Glimepiride	Glimepiride	39	suppressed
Donepezil Hcl	Donepezil Hcl	37	suppressed
Baclofen	Baclofen	36	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	35	suppressed
Azithromycin	Azithromycin	34	34
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	34	suppressed
Duloxetine Hcl	Duloxetine Hcl	34	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	34	suppressed
Synthroid	Levothyroxine Sodium	34	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	34	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	32	suppressed
Valsartan	Valsartan	32	suppressed
Clonazepam	Clonazepam	30	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	30	suppressed
Oxycontin	Oxycodone Hcl	30	suppressed
Lamotrigine	Lamotrigine	29	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	24
Clopidogrel	Clopidogrel Bisulfate	28	suppressed
Spironolactone	Spironolactone	28	suppressed
Atenolol	Atenolol	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	25
Farxiga	Dapagliflozin Propanediol	26	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Indomethacin	Indomethacin	24	suppressed
Naproxen	Naproxen	23	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	22	suppressed
Divalproex Sodium	Divalproex Sodium	22	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Ozempic	Semaglutide	22	suppressed
Aripiprazole	Aripiprazole	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Movantik	Naloxegol Oxalate	20	suppressed
Nebivolol Hcl	Nebivolol Hcl	20	suppressed
Topiramate	Topiramate	20	suppressed
Labetalol Hcl	Labetalol Hcl	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Mounjaro	Tirzepatide	19	suppressed
Risperidone	Risperidone	19	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	18	suppressed
Celecoxib	Celecoxib	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	15
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Trintellix	Vortioxetine Hydrobromide	18	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	18	suppressed
Armour Thyroid	Thyroid,pork	17	suppressed
Latanoprost	Latanoprost	17	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	11
Memantine Hcl	Memantine Hcl	15	suppressed
Nystatin	Nystatin	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Torsemide	Torsemide	15	suppressed
Bumetanide	Bumetanide	14	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	11
Gemfibrozil	Gemfibrozil	14	suppressed
Acarbose	Acarbose	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Digoxin	Digoxin	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Febuxostat	Febuxostat	13	suppressed
Metformin Hcl Er	Metformin Hcl	13	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	13	suppressed
Nyamyc	Nystatin	13	suppressed
Nystop	Nystatin	13	suppressed
Ramipril	Ramipril	13	suppressed
Travoprost	Travoprost	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	11	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Levobunolol Hcl	Levobunolol Hcl	11	suppressed
Methylphenidate Hcl Er (Cd)	Methylphenidate Hcl	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Scopolamine	Scopolamine	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed
Ursodiol	Ursodiol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error